chartexchange

CRSP
CRISPR Therapeutics AG
stockNASDAQ

At CloseNov 18, 2026 3:59:59 PM EST
40.16USD+0.025%(+0.01)3,979,338
Pre-marketNov 18, 2026 9:25:30 AM EST
40.22USD+0.174%(+0.07)
After-hoursNov 18, 2026 4:58:30 PM EST
40.79USD+1.569%(+0.63)
Loading…
Loading…
Healthcare
Biotechnology
CEO
Samarth Kulkarni
HQ
Zug, Zug, Switzerland
Previous Close
$40.15
Beta
1.88
52-Week High
$63.45 2026-07-06
52-Week Low
$39.80 2026-11-17
SMA 50
$51.23
SMA 200
$52.36
Avg. Vol 10D
2.60M
Avg. Vol 30D
1.81M
Avg. Vol 90D
1.66M
Relative Vol
2.20
96.49M
17,189,067
0.3700%
1,718
CRSP Profile

CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.

CRSP Performance
PeriodPriceDateChangeBeta
1W42.622026-11-12-5.82%2.461
1M50.042026-10-19-19.78%1.580
3M59.812026-08-19-32.89%1.857
6M47.592026-05-19-15.65%1.869
1Y50.732025-11-19-20.88%1.875
2Y46.972024-11-19-14.54%—
5Y82.442021-11-19-51.31%0.764
CRSP Stock Summary

CRISPR Therapeutics AG (NASDAQ:CRSP) stock price today is $40.14, and today's volume is 3,979,338. CRSP is down 0.025% today. The 30 day average volume is 1.81M. CRSP market cap is $3.89B with 97.00M shares outstanding.